Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-08-10 5:02 pm Purchase | 13G | Processa Pharmaceuticals Inc. PCSA | MANCHESTER MANAGEMENT CO LLC | 142,427 0.9% | 142,427 (New Position) | View |
| 2021-06-11 1:11 pm Purchase | 13G | Processa Pharmaceuticals Inc. PCSA | YUHAN (USA) CORP | 750,000 7.3% | 750,000 (New Position) | View |
| 2021-04-08 5:15 pm Sale | 13G | Processa Pharmaceuticals Inc. PCSA | MANCHESTER MANAGEMENT CO LLC | 1,053,300 6.8% | -476,700 (-31.16%) | View |
| 2020-10-13 2:22 pm Purchase | 13G | Processa Pharmaceuticals Inc. PCSA | MANCHESTER MANAGEMENT CO LLC | 1,530,000 11.2% | 1,530,000 (New Position) | View |
| 2020-10-13 10:08 am Purchase | 13D | Processa Pharmaceuticals Inc. PCSA | Young David | 1,991,168 14.2% | 1,991,168 (New Position) | View |